Medtronic
MDT
1,962 hedge funds and large institutions have $83.7B invested in Medtronic in 2022 Q4 according to their latest regulatory filings, with 212 funds opening new positions, 681 increasing their positions, 908 reducing their positions, and 152 closing their positions.
72% more call options, than puts
Call options by funds: $901M | Put options by funds: $523M
39% more first-time investments, than exits
New positions opened: 212 | Existing positions closed: 152
2% more funds holding
Funds holding: 1,932 → 1,962 (+30)
0.79% less ownership
Funds ownership: 81.76% → 80.96% (-0.79%)
5% less capital invested
Capital invested by funds: $87.9B → $83.7B (-$4.15B)
6% less funds holding in top 10
Funds holding in top 10: 33 → 31 (-2)
25% less repeat investments, than reductions
Existing positions increased: 681 | Existing positions reduced: 908
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$510M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$230M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$175M |
| 4 |
First Eagle Investment Management
New York
|
+$160M |
| 5 |
LP
Longview Partners
St Peter Port,
Guernsey
|
+$144M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lazard Asset Management
New York
|
-$554M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$282M |
| 3 |
CCM
Cullen Capital Management
New York
|
-$212M |
| 4 |
Goldman Sachs
New York
|
-$198M |
| 5 |
Neuberger Berman Group
New York
|
-$181M |
MDT Hedge Fund Activity: Q4 2022 in Review
1,962 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q4 2022, worth a combined $83.7B — down 4.7% from $87.9B a quarter earlier.
Buyers outnumbered sellers: 212 funds opened new MDT positions and 152 closed out — a net gain of 60 holders — while 681 added to existing stakes and 908 trimmed.
The largest buyer was BlackRock, adding an estimated $510M. The largest seller was Lazard Asset Management, cutting an estimated $554M.
- 1,962 institutional investors held Medtronic (MDT) as of Q4 2022, up from 1,932 in Q3 2022.
- Funds reported $83.7B of Medtronic stock for Q4 2022, down 4.7% quarter-over-quarter.
- 212 funds opened new Medtronic positions in Q4 2022 and 152 closed out, a net change of +60 holders.
- The largest Medtronic buyer in Q4 2022 was BlackRock, an estimated $510M added.
- The largest Medtronic seller in Q4 2022 was Lazard Asset Management, an estimated $554M sold.
Based on aggregated 13F filings for Q4 2022.